Amaryllis H. Van Craenenbroeck

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Transcriptional and spatial profiling of the kidney allograft unravels a central role for FcyRIII+ innate immune cells in rejection

Baptiste Lamarthée, Jasper Callemeyn, Yannick Van Herck et al. · Nature Communications · 2023 · 109 citations · Full text

Effect of Moderate Aerobic Exercise Training on Endothelial Function and Arterial Stiffness in CKD Stages 3-4: A Randomized Controlled Trial

Amaryllis H. Van Craenenbroeck, Emeline M. Van Craenenbroeck, Katrijn Van Ackeren et al. · American Journal of Kidney Diseases · 2015 · 106 citations

Physical Activity, Kinesiology, Exercise +10

Impaired vascular function contributes to exercise intolerance in chronic kidney disease

Amaryllis H. Van Craenenbroeck, Emeline M. Van Craenenbroeck, Katrijn Van Ackeren et al. · Nephrology Dialysis Transplantation · 2016 · 62 citations · Full text

Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering

Thibaut Vaulet, Gillian Divard, Olivier Thaunat et al. · Journal of the American Society of Nephrology · 2021 · 62 citations · Full text